TerminatedPhase 3

A Randomised Single Centre Study to Compare the Long-term Performance of 4 Designs of the DePuy Ultima LX Stem in Primary Total Hip Replacement

Stopped: The final assessments were conducted late and in a reduced format due to resource limitations at the site.

United Kingdom164 participantsStarted 1997-05

Plain-language summary

The purpose of this study is to compare the performance of 4 designs of the DePuy Ultima LX hip stem in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to one of the 4 designs of the DePuy Ultima LX hip stem and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.

Who can participate

Age range60 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Current indications for primary total hip arthroplasty utilising a cemented femoral component. These include pain, deformity and loss of function which are not responsive to medical treatment Exclusion Criteria: i) Revision Total Hip Arthroplasty ii) Rheumatoid arthritis iii) Age greater than 80 years at time of surgery iv) Age less than 60 years at time of surgery v) Previous hip joint sepsis vi) Obesity vii) Patient likely to remain housebound once rehabilitation is complete

What they're measuring

Stem movement measured radiographically at 2 years

Timeframe: 2yrs post-surgery

Trial details

NCT IDNCT00208351

SponsorDePuy International

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2004-11

View on ClinicalTrials.gov More Osteoarthritis trials